The American Association for Homeopathic Products

2025 AAHP Semiannual Membership Meeting
2025-10-17 11:00 - 13:00 (America/New_York) | Virtual
AAHP Semiannual Membership Meeting

Exclusive to AAHP Members is this semiannual briefing on the latest legal and regulatory issues from AAHP Legal Counselor Al Lorman, Esq. and on federal programs affecting your business from AAHP Lobbyist Pete Evich of Van Scoyoc Associates. Emerging issues and critical topics will be addressed. Additionally, AAHP officers will provide updates on association projects.

Registration Now Open

Event Information

Virtual via Zoom
Friday, October 17, 2025 from 11:00am-1:00pm EDT
Complimentary for AAHP Members (registration required)
Closed to non-members

Please do not de-value your membership by sharing the meeting link with non-members.
Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda:
coming soon!
Please contact AAHP Secretary Eric L. Foxman via email at Info@AAHP.Info or by voice message at 513-402-8847 with questions or concerns.

Registration Now Open

AAHP 2026 Annual Membership Meeting (and Tribute to Eric Foxman)
2026-03-13 11:00 - 13:00
AAHP Annual Membership Meeting (and Tribute to Eric Foxman)
This two-part event starts with a business briefing exclusively for AAHP members. The second part is open to all in the homeopathic community as we honor Eric Foxman as he retires from AAHP.

Registration Now Open

Event Information

Virtual via Zoom
Friday, March 13, 2026
Complimentary
Registration required to receive your individual link

Who Should Attend at AAHP Member Companies

Government Affairs Team
Compliance Officers and Quality Assurance Team
Lab and Production Managers
Marketing Team
R&D Team
Company Executives, including CEOs

Agenda

President’s Welcome and Overview
Mark Land, AAHP President

AAHP Board Elections
Represent your member company in the open seats!

Legal Update
Al Lorman

ANSI Considerations for Homeopathic Products
Robert Melo, President of OHM Pharma and AAHP Board Member

Impactful Transitions
Pete Evich, Van Scoyoc Associates

Tribute to Secretary Eric Foxman
Honoring his retirement after 45 years of service to the homeopathic community

Please contact Association Manager Hayley Sotolotto via email at info@theaahp.org or by voice message at (413) 515-8133 with questions or concerns.

FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
2026-06-10 12:00 - 13:30
FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
Hear directly from FDA at AAHP’s upcoming webinar. Learn from the agency about compliance trends and inspection insights relevant to homeopathic drug manufacturers through AAHP’s ongoing Compliance Through Education program.
About the Program
GMP compliance-related issues remain the leading cause of FDA warning letters across the homeopathic industry. This webinar brings together regulatory perspective and industry expertise to help manufacturers better understand what FDA is looking for during inspections.
Attendees will gain practical insight into recent compliance actions, as well as a deeper understanding of common compliance gaps observed during facility inspections so companies can better prepare for their next inspection.
Event Information

Virtual via Zoom
Wednesday, June 10, 2026
12:00 PM – 1:30 ET
Complimentary to members and non-members

Registration Now Open

Featured Speakers

Francis Godwin, MBA
Director, Office of Manufacturing Quality (OMQ), Office of Compliance, CDER, FDA Francis Godwin will provide an FDA perspective on recentcompliance actions affecting homeopathic drug products, drawing on his extensive experience overseeing domestic and international CGMP compliance activities.

Eric L. Foxman, RPh (Ret.)
Senior Scientist, HPUS; Former AAHP Secretary and Board Member
With more than four decades of experience in the homeopathic industry, Eric Foxman will present a retrospective review of FDA 483 observations of inspections of homeopathic manufacturing sites, highlighting key trends and lessons to be learned.
What You Will Learn

Overview and examples of inspection compliance.

FDA’s hot topics which result in warning letters.

What inspection observations are made most often across the board.

What initial areas companies can focus on, which will make a positive difference in the 483 list of observations.

An overview of the breadth of observations for a second pass at increasing compliance before the next inspection occurs.

Who Should Attend
This seminar is a must-attend for domestic and foreign firms who manufacture, label, pack, or hold homeopathic drug products for sale in the United States.

Quality Staff

Legal & Regulatory Staff

Product Leads

Product R&D Staff

Company Leaders (President/CEO)

And those similarly responsible at your contract manufacturer

Please contact info@theaahp.org or (413) 515-8133 with questions or concerns.
